The effect of the sun on expression of β‐catenin, p16 and cyclin d1 proteins in melanocytic lesions

Background.  The tumour suppressor gene product, p16, is often inactivated during melanoma malignant progression. Although the importance of p16 in melanomas is well documented, its relationship with cyclin D1, β‐catenin and ultraviolet radiation (UVR) remains unclear.

[1]  Wei Li,et al.  The role of cell cycle regulatory proteins in the pathogenesis of melanoma , 2006, Pathology.

[2]  H. Moch,et al.  p16 expression in primary malignant melanoma is associated with prognosis and lymph node status , 2006, International journal of cancer.

[3]  L. Akslen,et al.  Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma , 2005, Clinical Cancer Research.

[4]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[5]  T. Papp,et al.  Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi , 2005, Melanoma research.

[6]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[7]  M. Rao,et al.  Cyclin D1 expression in melanocytic lesions of the skin. , 2005, Annals of diagnostic pathology.

[8]  A. Ouhtit,et al.  Towards a Better Understanding of the Molecular Mechanisms Involved in Sunlight-Induced Melanoma , 2005, Journal of biomedicine & biotechnology.

[9]  M. Herlyn,et al.  Recent advances in melanoma biology. , 2004, The oncologist.

[10]  J. Nesland,et al.  Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  L. Larue,et al.  Beta-catenin in the melanocyte lineage. , 2003, Pigment cell research.

[12]  L. Kanter,et al.  Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  D. Pinkel,et al.  Cyclin D1 is a candidate oncogene in cutaneous melanoma. , 2002, Cancer research.

[14]  A. Chompret,et al.  Genetic and environmental factors in cutaneous malignant melanoma. , 2002, Biochimie.

[15]  T. Saida,et al.  Loss of β‐catenin expression associated with disease progression in malignant melanoma , 2001, The British journal of dermatology.

[16]  D. Schadendorf,et al.  Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions* , 2001, Journal of clinical pathology.

[17]  J. Nesland,et al.  Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  C. Berking,et al.  Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation , 2000, Melanoma research.

[19]  S. Pavey,et al.  Ultraviolet radiation induces p16CDKN2A expression in human skin. , 1999, Cancer research.

[20]  M. Ueda,et al.  Induced expression of p16 and p21 proteins in UVB-irradiated human epidermis and cultured keratinocytes. , 1999, Journal of dermatological science.

[21]  P. Hersey,et al.  Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma: deficient alpha-catenin expression is associated with melanoma progression. , 1999, Pathology.

[22]  K. Syrigos,et al.  E‐cadherin/catenin complex in benign and malignant melanocytic lesions , 1998, The Journal of pathology.

[23]  N. Hayward,et al.  Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation. , 1998, Mutation research.

[24]  Y. Collan,et al.  Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage , 1997, International journal of cancer.

[25]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.